000			02076 a2200589 4500
005			20250516061050.0
264		0	_c20120207
008			201202s 0 0 eng d
022			_a1524-4571
024	7		_a10.1161/CIRCRESAHA.111.255695 _2doi
040			_aNLM _beng _cNLM
100	1		_aCheng, Hui
245	0	0	_aA novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity. _h[electronic resource]
260			_bCirculation research _cDec 2011
300			_a1401-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAnimals, Genetically Modified
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBenzenesulfonates _xpharmacology
650	0	4	_aCardiotoxins _xpharmacology
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aGefitinib
650	0	4	_aIndoles _xpharmacology
650	0	4	_aMale
650	0	4	_aModels, Animal
650	0	4	_aMyocytes, Cardiac _xcytology
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-raf _xantagonists & inhibitors
650	0	4	_aPyridines _xpharmacology
650	0	4	_aPyrroles _xpharmacology
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aZebrafish
700	1		_aKari, Gabor
700	1		_aDicker, Adam P
700	1		_aRodeck, Ulrich
700	1		_aKoch, Walter J
700	1		_aForce, Thomas
773	0		_tCirculation research _gvol. 109 _gno. 12 _gp. 1401-9
856	4	0	_uhttps://doi.org/10.1161/CIRCRESAHA.111.255695 _zAvailable from publisher's website
999			_c21231138 _d21231138